FDA Tackles Obesity With Nutraceuticals Guidance, Warning Letters
This article was originally published in The Tan Sheet
Executive Summary
A string of warning letters issued by FDA to several dietary supplement companies making weight loss products is being billed as part of the agency's aggressive effort to combat obesity